LifeStance Health Group, Inc. (LFST)

NASDAQ • Healthcare

$12.93

+$0.36 (+2.9%)

Market closed

Last close at October 23, 2026 at 20:00 UTC

Open$12.55

Day Range$12.42 - $12.95

Avg. Volume (3M)3M

Market Cap$4.9B

P/E Ratio99.5

52 Week Range

$4.77$13.56

Next EarningsIn 11 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026

Revenueeverything earned$435.3M100%

Gross Profitminus cost of goods$153M35%

Operating Incomeminus R&D and overhead$30.6M7%

Net Incomeminus taxes and the rest$23.6M5%

In plain terms: out of every $100 in revenue, LifeStance Health Group, Inc. keeps $5 as net profit.

Fundamentals & Financials

Revenue (TTM)

$1.5B

Net Income (TTM)

$50.6M

EPS (TTM)

$0.13

ROA (TTM)

2.32%

Current Ratio

1.38

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

+66.7%Q3 2025-$0.01

+127.7%Q4 2025$0

+3291.5%Q1 2026$0.03

+300.0%Q2 2026$0.04

+83.2%Q3 2026$0.06

Nov 5

in 11 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Next report — what to expect

LifeStance Health Group, Inc. (LFST) reports on November 5, 2026. Wall Street expects EPS of $0.037 on revenue of $431.6 million. For trailing context, revenue grew +26.1% year over year last quarter. LFST has beaten EPS in 8 of 8 most recent quarters, making profitability versus consensus a key focus.

View full earnings history

About LifeStance Health Group, Inc.

LifeStance Health Group, Inc. provides outpatient mental health care in the healthcare services sector through psychiatric evaluations and treatment, therapy, and assessment services, and its shares trade on NASDAQ under the ticker LFST. Across FY2025, the company generated $1.4 billion in revenue. It operates as a multi-site provider of behavioral care rather than an acute-care facility business.

Name

LifeStance Health Group, Inc.

CEO

David Patrick Bourdon

Website

www.lifestance.com

Industry

Healthcare

Year Founded

2017

Employees

8,542

Today's Snapshot

AI-generated

LFST closed 3% higher, within reach of the top of its 52-week range. LFST reports earnings on 5 November.

Trading Volume

Below 10d avg (3.0M)

2.9M

vs S&P 500 Today

Strong Outperformance

+3.47%

Updated: October 23, 2026 at 20:11 UTC

Technical Indicators

6 Buy1 Neutral1 Sell

LFST shows a constructive bias as the price is above short-, medium- and long-term moving averages, backed by a strong OBV and bullish momentum signals including a high CCI and a mildly positive MACD. RSI sits in the upper range, indicating positive momentum, while stochastic and the upper Bollinger band suggest the name is near overbought levels. ADX indicates only modest trend strength and ATR is moderate, and the classic pivot lies slightly below the market providing nearby support. Technical takeaway: Buy.

All signals

EMA (5 indicators)$9.55 - $12.37
Buy
RSI (14)61.84
Neutral
Stochastic %K (14, 3, 3)85.83
Sell
MACD Level (12, 26)0.06
Buy

Peers & Related Assets

BTSGBrightSpring Health Services, Inc. Common Stock

$60.11-1.2%

UHSUniversal Health Services, Inc.

$186.89-0.7%

HIMSHims & Hers Health, Inc.

$27.71-4.9%

ACHCAcadia Healthcare Company, Inc.

$31.51-1.2%

PRVAPrivia Health Group, Inc.

$22.41-2.1%

LFMDLifeMD, Inc.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.